Featured Research

from universities, journals, and other organizations

Severe asthma more prevalent than thought, related to pronounced nasal symptoms

Date:
November 27, 2010
Source:
BioMed Central Limited
Summary:
People with multi-symptom asthma more often have night-time awakenings due to asthma-symptoms, a sign of severe asthma. Researchers have shown that asthma with multiple symptoms is more highly prevalent than previously suggested, comprising 20- 25% of all asthmatics.

People with multi-symptom asthma more often have night-time awakenings due to asthma-symptoms, a sign of severe asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have shown that asthma with multiple symptoms is more highly prevalent than previously suggested, comprising 20- 25% of all asthmatics.

Investigators from the University of Gothenburg have performed a large-scale epidemiological survey in West Sweden, comprising of a random sample of 30,000 individuals and a response rate of 62%. The authors have previously shown that the prevalence of asthma is high, at approximately 8.5%, but stable over the last two decades. In this study they found that the prevalence of severe asthma is as high as 2%. Lead researcher Jan Lφtvall said, "Individuals reporting multiple asthma symptoms are likely to have a more severe form of asthma, which has been shown to increase the risk of asthma attacks, increases health care utilization and negatively influence quality of life."

The report further shows that the risk of having asthma with multiple symptoms is substantially increased in those reporting symptoms from the nose, including blocked nose and runny nose. Specifically, the investigators show that signs of chronic rhinosinusitis, which has been defined as having at least two symptoms of nasal blockage, runny nose, lack of smell and/or pain from sinuses over at least 12 weeks, further increase the risk of severe asthma. This is the first study based on an epidemiological cohort showing a close relationship between severe nasal symptoms and severe asthma.

According to Lφtvall, "Our study strongly supports the concept that nasal disease and asthma often are closely related, and argues that doctors should consider whether asthma patients with symptoms from the nose have severe asthma, possibly requiring more intense intervention."


Story Source:

The above story is based on materials provided by BioMed Central Limited. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jan Lotvall, Linda Ekerljung and Bo Lundback. Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis - evidence from the West Sweden Asthma Study. Respiratory Research, 2010, 11:163 DOI: 10.1186/1465-9921-11-163

Cite This Page:

BioMed Central Limited. "Severe asthma more prevalent than thought, related to pronounced nasal symptoms." ScienceDaily. ScienceDaily, 27 November 2010. <www.sciencedaily.com/releases/2010/11/101126094449.htm>.
BioMed Central Limited. (2010, November 27). Severe asthma more prevalent than thought, related to pronounced nasal symptoms. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/11/101126094449.htm
BioMed Central Limited. "Severe asthma more prevalent than thought, related to pronounced nasal symptoms." ScienceDaily. www.sciencedaily.com/releases/2010/11/101126094449.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins